BEIJING, Sept. 16, 2019 /PRNewswire/ -- A news report by China Daily discussing healthcare advances over 70 years in China:

KELOWNA, BC, Sept. 16, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytic

TORONTO and CAMBRIDGE, MA, Sept. 16, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced that Executive Ch

HORSHAM, Pa., Sept. 16, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking first-in-class approval of TREMFYA® (guselkumab) for the treatment of adult patients with active psoriati

DALLAS, Sept. 16, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held today in New York City. Details of SWK's presentation are as follow

CLEVELAND, Sept. 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Penn State Health has entered into a master agreement for the purchase of up to four MRIdian systems, placing an order for its first system today. Penn State Health, which includes the Milton S. Hershey Medical Center and St. Joseph Medical Center, has selected MRIdian to offer pe

PETAH TIKVA, Israel, Sept. 16, 2019 /PRNewswire/ -- DreaMed Diabetes, developer of personalized diabetes management solutions, announced today that it has received U.S Food and Drug Administration (FDA) clearance as well as CE Mark for DreaMed Advisor Pro, an

PHILADELPHIA, Sept. 16, 2019 /PRNewswire/ -- Proton Therapy Partners (PTP) has named Kurt Morath its Vice President of Operations. In this role, Morath will lead the planning, building and operation of PTP's proton therapy centers nationwide. He will also oversee the company's management and consulting business.

PRINCETON, N.J., Sept. 16, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Daniel P. Ring as Vice President of Business D

HAYWARD, Calif., Sept. 16, 2019 /PRNewswire/ -- Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS), today announced it has established a subsidiary in China to market its CleanPlex® products to the rapidly growing Chinese market. Following a distribution agree